A Study to Compare the Effectiveness and Safety of T1695 Versus Ciclosporin in Participants With Moderate to Severe Vernal Keratoconjunctivitis

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(11 sites)

India

Disha Eye Hospitals - Barrackpore, Kolkata, West Bengal

M&J Institute of Ophthalmology, Ahmedabad

Netralaya Super Speciality Eye Hospital, Ahmedabad

Narayana Nethralaya, Bangalore

L. V. Prasad Eye Institute (LVPEI), Hyderabad

Agrawal Hospital, Jaipur

Regional Institute of Ophthalmology (RIO) - Kolkata, Kolkata

Regional Institute of Ophthalmology, Patna, Patna

PBMA'S H. V. Desai Eye Hospital, Pune

Shivam Retina Clinic and Eye Hospital, Surat

L V Prasad Eye Institute, Visakhapatnam